Related Experiment Video
Updated: Jun 2, 2025
08:32
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
9.5K
Interrogation of the tumor microenvironment by nanoparticles
Prasanta Panja1, Upender Manne2, Vibhudutta Awasthi3
1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Cancer Letters
|January 13, 2025
Summary
Nanoparticles can disrupt tumor microenvironment (TME) crosstalk for cancer therapy. This approach targets cancer cells and signaling pathways, offering new avenues for treatment.
Area of Science:
- Oncology
- Biotechnology
- Materials Science
Background:
- The tumor microenvironment (TME) facilitates cancer progression through complex cell-cell communication.
- Understanding this multicellular crosstalk is crucial for developing effective cancer therapies.
Purpose of the Study:
- To review the therapeutic potential of nanoparticles in disrupting TME crosstalk.
- To explore nanoparticle mechanisms, challenges, and future directions in cancer treatment.
Main Methods:
- Review of current literature on nanoparticle applications in cancer therapy.
- Analysis of nanoparticle design for targeting specific cells and delivering payloads.
- Discussion of mechanisms by which nanoparticles modulate the TME.
Main Results:
- Nanoparticles can be engineered to target specific cells within the TME.
- Therapeutic payloads delivered by nanoparticles can inhibit tumor growth, invasion, and metastasis.
- Mechanisms include immune modulation, growth factor signaling interference, and apoptosis induction.
Conclusions:
- Nanoparticle-based strategies offer a promising approach to disrupt TME crosstalk.
- Overcoming challenges like biocompatibility and delivery is key for clinical translation.
- Integration with existing therapies can enhance efficacy and enable personalized cancer medicine.
